These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8370919)

  • 41. Graves' ophthalmopathy and pretibial myxedema: pathogenesis and treatment.
    Chang TC
    J Formos Med Assoc; 1994 Mar; 93(3):185-90. PubMed ID: 7920055
    [No Abstract]   [Full Text] [Related]  

  • 42. [An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves' disease and thyroid eye disease].
    Perepelova MA; Zaitseva EL; Bessmertnaya EG; Grusha YO; Sviridenko NY; Galstyan GR
    Probl Endokrinol (Mosk); 2023 Aug; 69(4):32-37. PubMed ID: 37694865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenesis and treatment of pretibial myxedema.
    Kriss JP
    Endocrinol Metab Clin North Am; 1987 Jun; 16(2):409-15. PubMed ID: 3319589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased Tc-99m DTPA uptake in active Graves' ophthalmopathy and pretibial myxoedema.
    Alevizaki-Harhalaki M; Alevizaki C; Georgiou E; Proukauis C; Ikkos D
    J Nucl Med; 1983 Feb; 24(2):174-6. PubMed ID: 6337239
    [No Abstract]   [Full Text] [Related]  

  • 45. Follow-up of extended pterional orbital decompression in severe Graves' ophthalmopathy.
    Korinth MC; Ince A; Banghard W; Gilsbach JM
    Acta Neurochir (Wien); 2002 Feb; 144(2):113-20; discussion 120. PubMed ID: 11862510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of pretibial myxedema associated with Graves' disease: an immunohistochemical study of serum-derived hyaluronan-associated protein.
    Shishido M; Kuroda K; Tsukifuji R; Fujita M; Shinkai H
    J Dermatol; 1995 Dec; 22(12):948-52. PubMed ID: 8648004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Graves' disease presenting as localized myxedema in a thigh donor graft site.
    Missner SC; Ramsay EW; Houck HE; Kauffman CL
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):846-9. PubMed ID: 9810913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Severe Graves' acropachy and dermopathy. Three case reports].
    Proust-Lemoine E; Vantyghem MC; Bauters C; Nocaudie M; Wémeau JL
    Presse Med; 2005 Mar; 34(5):367-70. PubMed ID: 15859571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case report of EMO syndrome showing localized hyperhidrosis in pretibial myxedema.
    Kato N; Ueno H; Matsubara M
    J Dermatol; 1991 Oct; 18(10):598-604. PubMed ID: 1791240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel teprotumumab treatment of severe thyroid dermopathy; ototoxicity as an adverse side effect.
    Patel RT; Grider DJ; Ramey N
    Dermatol Online J; 2023 Feb; 29(1):. PubMed ID: 37040908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Course of proptosis in patients with Graves' disease after endoscopic orbital decompression.
    Ulualp SO; Massaro BM; Toohill RJ
    Laryngoscope; 1999 Aug; 109(8):1217-22. PubMed ID: 10443822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response to topical halcinonide following fractional carbon dioxide laser pretreatment in a pretibial myxedema patient.
    Xu Y; Ma R; Cai Y; Zheng X
    Indian J Dermatol Venereol Leprol; 2018; 84(6):763. PubMed ID: 29363626
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.
    Sendhil Kumaran M; Dutta P; Sakia U; Dogra S
    Int J Dermatol; 2015 Aug; 54(8):e280-6. PubMed ID: 26019115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elephantiasic pretibial myxedema in Graves' disease.
    Sharma VK; Sood A; Sood A; Singh MK
    J Assoc Physicians India; 2002 Nov; 50():1430-1. PubMed ID: 12583477
    [No Abstract]   [Full Text] [Related]  

  • 55. Coronal approach for rehabilitative orbital decompression in Graves' ophthalmopathy.
    Kalmann R; Mourits MP; van der Pol JP; Koornneef L
    Br J Ophthalmol; 1997 Jan; 81(1):41-5. PubMed ID: 9135407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein.
    Bahn RS; Gorman CA; Johnson CM; Smith TJ
    J Clin Endocrinol Metab; 1989 Sep; 69(3):622-8. PubMed ID: 2760173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Puzzles in practice. Case report. A 62-year-old black woman with known Graves' disease. Diagnosis: Graves' dermopathy (elephantiasic type) and Graves' acropachy.
    Mishriki YY
    Postgrad Med; 2010 Mar; 122(2):162-4. PubMed ID: 20203468
    [No Abstract]   [Full Text] [Related]  

  • 58. Extrathyroidal manifestations of Graves' disease: a 2014 update.
    Bartalena L; Fatourechi V
    J Endocrinol Invest; 2014 Aug; 37(8):691-700. PubMed ID: 24913238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower extremity manifestations of Graves' disease.
    Sauer P; Brandes B; Mahmarian RR
    J Foot Ankle Surg; 1995; 34(5):489-97. PubMed ID: 8590885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgG, IgA and C3 deposits in the extra-thyroidal manifestations of autoimmune Graves' disease: their in vitro solubilization by intravenous immunoglobulin.
    Antonelli A; Palla R; Casarosa L; Fallahi P; Baschieri L
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S31-5. PubMed ID: 8828945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.